AIBOTICS, INC.
AIBTOTCHealthcare · Medicinal Chemicals & Botanical Products · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2,183 | $0 | — | — | — | $0 |
| Operating income | −$1.8M | −$1.6M | −$616,724 | −$1.7M | −$2.7M | −$14,223 |
| Net income | −$2.2M | −$1.8M | −$1.2M | −$2.6M | −$2.8M | −$16,029 |
| Total assets | $874,673 | $1.5M | $2.2M | $387,395 | $1.3M | $110,747 |
| Total liabilities | $4.8M | $4.9M | $4.2M | $1.3M | $929,995 | $126,996 |
| Equity | −$4.0M | −$3.4M | −$2.0M | −$891,348 | $52,021 | −$16,249 |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 42.7M | 14.9M | 14.9M | 14.3M | 12.9M | 12.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −84501.7%
- Net margin
- −101500.3%
- Return on equity
- 56.0%
- Return on assets
- −253.3%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 552.8%
- Debt / equity
- —
- Book value / share
- $-0.09
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -97.51distress
- Accruals / assets
- −200.9%clean
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Apr 30, 2026 | 101,312 | 1.0 | +153403.0% |
| Apr 15, 2026 | 66 | 1.0 | 0.0% |
| Mar 31, 2026 | 66 | 1.0 | -99.9% |
| Mar 13, 2026 | 60,000 | 1.0 | -87.8% |
| Feb 27, 2026 | 490,034 | 1.0 | +100.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreementMar 24, 2025
- Entered a material agreement · Amended charter or bylawsAug 21, 2024
- Changed auditorMar 28, 2024
- Entered a material agreement · Completed an acquisition or disposition · Unregistered equity sale · Regulation FD disclosureDec 5, 2023
- Prior financials not reliable (restatement)May 3, 2023
- Terminated a material agreement · Regulation FD disclosureFeb 22, 2023
- Entered a material agreement · Regulation FD disclosureMay 19, 2022
- Entered a material agreementJan 14, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- NT 10-QFORM NT 10-Q FILINGMay 15, 2026
- 10-KAIBOTICS, INC. - FORM 10-K SEC FILINGApr 15, 2026
- NT 10-KAIBOTICS, INC.- NT10KMar 31, 2026
- S-8AIBOTICS INC. - FORM S-8 FILINGJan 28, 2026
- 10-QAIBOTICS, INC. - FORM 10-Q SEC FILINGNov 19, 2025
- NT 10-QFORM NT 10-Q FILINGNov 14, 2025
- 10-QAIBOTICS, INC. - FORM 10-Q SEC FILINGAug 19, 2025
- NT 10-QFORM NT 10-Q FILINGAug 14, 2025
- 4PRIMARY DOCUMENTJul 28, 2025
- 253G2AIBOTICS FORM 253(G)(2)Jul 3, 2025
- QUALIFJul 1, 2025
- CORRESPJun 27, 2025
- 1-A/AJun 27, 2025
- CORRESPJun 24, 2025
- 1-A/AJun 2, 2025